Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nomination Committee’s proposal for the Board of Directors ahead of the Annual General Meeting of Starbreeze AB

STOCKHOLM (12 January 2018) - The Nomination Committee of Starbreeze AB has decided to propose to the Annual General Meeting 2018 that the Board be composed of seven ordinary members without alternates. The Nomination Committee proposes re-election of directors Ulrika Hagdahl, Michael Hjorth, Bo Andersson Klint, Harold Kim and Matias Myllyrinne, and election of Kristofer Arwin and Åsa Wirén. Michael Hjorth is proposed for re-election as Chairman. Director Eva Redhe has declined re-election. Kristofer Arwin, BSc in Business Administration and Economics, is Chairman and co-founder of

SenzaGen’s final validation report of GARDskin™ submitted to regulatory authorities – reveals highest test prediction accuracy in the field

Lund, January 12, 2018 - SenzaGen (Nasdaq First North: SENZA) announces today that the company has submitted the final report for the validation of GARDskin™ to the regulatory authorities. Global regulatory approval and recommendation by ECVAM and OECD on the use of GARDskin is expected in April 2019. The final result presented in the report shows an unprecedented over all prediction accuracy of 93,8% in determining whether chemical substances are at risk of causing allergies. This proves that GARDskin™ outperforms all current available validated methods.The analysis of the data has been

CombiGene and Cell and Gene Therapy Catapult sign agreement to develop manufacturing process for novel gene therapy to treat epilepsy

Collaboration between Cell and Gene Therapy Catapult (CGT Catapult) and Swedish gene therapy company CombiGene will take a unique therapy one step closer to helping sufferers of hard to treat epilepsy.London, UK, and Lund, Sweden, 12 January 2018 – CGT Catapult and CombiGene today announced that they will be collaborating on a project to develop manufacturing processes for CombiGenes drug candidate CG01, a novel gene therapy for treatment of epilepsy. The collaboration aims to develop a complete and final manufacturing process which will allow CombiGene to progress to commercial GMP

Opus wins new concession in Chile

Opus has won a public tender and signed an 8-year vehicle inspection concession in Valparaíso, Chile.Opus’ Vehicle Inspection division has signed a new contract with El Ministerio de Transportes y Telecomunicaciones in Chile, to design, build and operate one of its vehicle safety inspection programs in the region of Valparaíso, using the most advanced technologies and efficient management practices. The program includes two stations; one in Viña del Mar serving light-duty vehicles, and one in Casablanca serving both heavy- and light-duty vehicles. It is expected to generate

Nokian Tyres will publish its 2017 Financial Statement Release on February 2, 2018

Nokian Tyres plc Press Release January 12, 2018, 09:15 a.m. Nokian Tyres will publish its 2017 Financial Statement Release on February 2, 2018 at 8.00 a.m. Finnish time. After publication, the release and presentation material will be available on the company's website at www.nokiantyres.com/company/investors/ The result presentation for analysts and media will be held on February 2, 2018 at 10.00 a.m. Finnish time at Hotel Kämp (address Pohjoisesplanadi 29, Helsinki). President and CEO Hille Korhonen will present the result 2017 and answer questions from the audience. The

KONE publishes January 1-December 31, 2017 Financial Statement Bulletin on Thursday, January 25, 2018 at 12:30 p.m. EET and Financial Statements 2017 at 12:45 p.m. EET

KONE Corporation, press release, January 12, 2018 at 9.05 a.m. EETKONE publishes January 1-December 31, 2017 Financial Statement Bulletin on Thursday, January 25, 2018 at 12:30 p.m. EET and Financial Statements 2017 at 12:45 p.m. EET Financial Statement Bulletin and Financial Statements KONE Corporation will publish its Financial Statement Bulletin for the January 1-December 31, 2017 accounting period on Thursday, January 25, 2018 at 12:30 p.m. EET. The report will be available on www.kone.com after publishing. The Financial Statements for 2017 will be published on the same day

Staffan Bohman proposed new Chairman of AB Electrolux

In preparation for the Electrolux Annual General Meeting on April 5, the Electrolux Nomination Committee proposes the election of Staffan Bohman as new Chairman of the Board of Directors of AB Electrolux. The committee also proposes re-election of Petra Hedengran, Hasse Johansson, Ulla Litzén, Bert Nordberg, Fredrik Persson, David Porter, Jonas Samuelson, Ulrika Saxon and Kai Wärn as Board Members. Ronnie Leten has, as previously communicated, declined re-election.Staffan Bohman is Chairman of Höganäs AB, Ipco AB and Upplands Motor Holdings AB, and Board Member in Atlas Copco AB. He is also

Genetic analysis can improve depression therapy

[PRESS RELEASE 2018-01-12] The failure of drugs such as SSRIs, used to treat depression, can be a result of genetic variations in patients. Variations within the gene that encodes the CYP2C19 enzyme results in extreme differences in the levels of escitalopram achieved in patients, according to a new study published in The American Journal of Psychiatry. Prescribing the dose of escitalopram based on a patient’s specific genetic constitution would greatly improve therapeutic outcomes. The study was conducted at Karolinska Institutet in Sweden in association with researchers at Diakonhjemmet

Nordea’s Fourth Quarter and Full Year Results 2017 will be presented on Thursday 25 January 2018

The report will be published at approximately 07.00 CET. Press conferenceTime: 09.00 CET. Registration opens at 08.30.For security reasons, a valid identity card is required. Venue: Smålandsgatan 17, Stockholm.Casper von Koskull, President and Group CEO, will present the results.The presentation will be conducted in English and can be viewed live (direct link).  You will also find the presentation material at www.nordea.com/ir.To attend the press conference please contact: Afroditi Kellberg at Nordea via e-mail afroditi.kellberg@

Skanska builds research facility in Virginia, USA, for USD 68M, about SEK 580M

Skanska has signed a contract with Carilion Clinic, a collaboration between Carilion Clinic and Virginia Tech, to build a research facility in Roanoke, Virginia, USA. The contract is worth USD 68M, about SEK 580M, which will be included in its US order bookings for the fourth quarter 2017.Skanska will build a four-story research laboratory of approximately 13,000 square meters. The building will complete the Virginia Tech Carilion Biomedical Research addition on the Virginia Tech Carilion Health Sciences and Technology Campus. Construction began in December 2017 and is expected to be

NCC to construct Dansmästaren project including 133 rental units in Uppsala

NCC is to construct the Dansmästaren project in partnering form with Uppsalahem AB and Uppsala Parkerings AB. The project will include 133 rental apartments, a parking facility and large premises in the Rosendal district of Uppsala, Sweden. The order value is SEK 290 million.“Uppsala is expanding at a rapid rate and there is still substantial demand for rental units. With NCC as a partner, we will be able to add a number of much-needed rental units in a new city district,” says Niosha Baghaei, Construction Manager, Uppsalahem AB. Dansmästaren will be have a strategically important

Read original

LeoVegas enters into agreement to acquire rapidly growing UK casino operator for GBP 65 million

LeoVegas AB (publ) ("LeoVegas") has entered into an agreement to acquire the assets of Intellectual Property & Software Limited ("IPS") and other related assets from two further companies, including top brands such as 21.co.uk, Slotboss, Bet UK and UK Casino. During the fourth quarter of 2017, IPS generated revenues of GBP 11.7 million and, together with the companies whose assets are also being acquired as part of the transaction, an adjusted EBITDA* of GBP 3.8 million. The acquisition will be financed by cash and from existing debt facilities for a total consideration of GBP 65.0 million (

Preliminary information on KONE's 2017 financials and outlook for 2018: Q4 2017 sales was higher than expected, the pressure on adjusted EBIT margin is expected to continue in 2018

KONE Corporation, stock exchange release, January 12, 2018 at 9.00 a.m. EETPreliminary information on KONE's 2017 financials and outlook for 2018: Q4 2017 sales was higher than expected, the pressure on adjusted EBIT margin is expected to continue in 2018 KONE's 2017 full year sales was higher than expected due to strong new equipment deliveries in the fourth quarter. Based on preliminary information, KONE's sales grew by 4.2% at comparable exchange rates in 2017 against the earlier estimated 1-3%. The preliminary adjusted EBIT for the full year 2017 was EUR 1,230 million which is

Lindab International AB (publ): New President and CEO in Lindab

The Board of Lindab International AB has appointed Ola Ringdahl as new CEO and President. Ola Ringdahl will replace Fredrik von Oelreich, who has been acting CEO since September 29 2017."I'm very pleased to be able to present Ola Ringdahl as new CEO and President", says the Chairman of the Board, Peter Nilsson. "Ola will through his competence and experience create spirit and stability to the company. Ola has as CEO for Nord-Lock Group showed a deep knowledge how to create growth in a complex and innovative business. I'm convinced that he will be able to lead Lindab to new successes".

Kungsleden issues bond loans of SEK 850 million

Kungsleden AB (publ.)(”Kungsleden”) has issued two senior unsecured bond loans with a duration of three respectively eighteen months under its MTN program. The loan amounts in total to SEK 850 million.The three- year loan of SEK 250 million has a floating rate coupon of STIBOR 3M plus 1.8 per cent which corresponds to an initial coupon of about 1.38 per cent. The loan with a duration of eighteen months with a loan amount of SEK 600 million has a fixed rate equivalent to 1.5 year mid swap rate plus 1.2 per cent, with a coupon of 0.95 per cent. The average interest rate of the loans amounts

Publishing of YIT Corporation's Financial Statements Bulletin 2017 on February 1, 2018

YIT Corporation Investor News January 12, 2018 at 8:00 a.m.YIT Corporation's Financial Statements Bulletin for 2017 will be published on Thursday, February 1, 2018 at approximately 8:00 a.m. Finnish time (EET, approx. 06:00 a.m. GMT). The stock exchange release and the presentation materials in Finnish and in English will be published at that time on the company's website at www.yitgroup.com/investors.  News conference for investors and media  YIT will arrange a news conference on Thursday, February 1, 2018 at 11:00 a.m. Finnish time (EET, at 9:00 a.m. GMT) at YIT's head office,

Italian metals industrial consulting firm Danieli strengthens their cyberdefense using Clavister

Through local partner Eyelink, Danieli invests in Clavister’s solutions to protect their critical processes and infrastructure.Örnsköldsvik, Sweden. January 12, 2018. Clavister (CLAV: NASDAQ), a leader in high-performance network security solutions, has concluded a SEK 1.7M deal with Italian metals industrial consultancy Danieli through Clavister partner Eyelink. The upgrade of their security infrastructure to the latest models from Clavister makes it more modern and resilient as well as higher performing, helping them combat modern cyber threats that ensure business continuity. The new

Preliminary results for Edgeware Q4 2017

Edgeware’s net sales in the fourth quarter 2017 will amount to about SEK 68 million (85), which means the full year net sales will amount to about SEK 237 million (252).The calculated EBIT for the fourth quarter will amount to about SEK 6 million (10), which means a full year calculated EBIT of about SEK 12 million (19). The gross margin for the quarter amounted to about 74 %. These preliminary numbers are not yet audited. “Based on experience from previous years’ seasonality and revenue split between the quarters, the fourth quarter has not developed in the way we had expected, explains

Growth in Qt Group Plc’s net sales for 2017 falls slightly below earlier estimate

Qt Group Plc Stock Exchange Release January 11, 2018 at 6:40 PM At the end of 2017, the growth of Qt Group’s net sales was weighed down by the strengthening of the euro compared to the dollar and the postponing of several medium-sized contracts until 2018. For these reasons, the growth in the company’s net sales for 2017 falls slightly below the growth forecast that was published on 23 October 2017. In the previous forecast, the company estimated its net sales to grow in 2017 by approximately 15 per cent from the previous year.Based on the preliminary figures before auditing, the company’

SaltX secures additional 15 MSEK funding for accelerating the market introduction of HeatBoost in Europe

NASDAQ First North listed SaltX Technology has been awarded 15 MSEK in funding from InnoEnergy - part of the European Institute of Innovation & Technology - to further accelerate the market introduction of SaltX HeatBoost application and make it ready for field trials throughout Europe.As recently communicated SaltX, has already been awarded  20 MSEK for this project by the European Commission and its H2020 program. "With this additional funding, we will be able to speed up the time to market as we can

Eurocine Vaccines obtains authorization to conduct the next study with Immunose™ FLU

Eurocine Vaccines today announced that the company has received authorization to conduct a phase I/II clinical study on the quadrivalent influenza vaccine candidate Immunose™ FLU, a novel nose drop formulation based on the company´s technology Endocine™ and inactivated split antigens.Eurocine Vaccines submitted applications to the Swedish Medical Products Agency, MPA, and to the Ethics Committee in early November. The Company announced today that authorizations to conduct the study have been received from both. - Our thoroughly prepared application and qualified dialogue with the Swedish

Oboya establishes a new company in the Netherlands

Oboya Horticulture Industries AB (publ) ("Oboya") has decided to establish a new wholly-owned company in the Netherlands with activities in marketing and selling Oboya's product range to customers in the Central European market. The sales company will be called Oboya Horticulture Holland B.V. with its registered office in Heenvliet, Netherlands. The company will be established during the first quarter of 2018 with operations in marketing, sourcing and selling Oboya's product range to customers in the Central European market. The company will be headed by Ed Salome, Dutch citizen who has

Preliminary information on Stockmann’s revenue and operating profit in 2017

STOCKMANN plc, Inside Information 11.1.2018 at 16:30 EET According to preliminary financial information, the Stockmann Group’s revenue was approximately EUR 315 million in the fourth quarter of 2017. Revenue in comparable businesses* was on a par with the previous year. Lindex’s revenue in comparable stores was down by 1% in the quarter. Stockmann Retail’s fourth-quarter revenue was on a par with the previous year in comparable businesses. The Group’s revenue for the full year 2017 amounted to approximately EUR 1 056 million, down by 1% in comparable businesses. The Stockmann Group’s

There are no items matching the current filter
There are no more items matching the current filter
Back to top